Isracann Bioscience Facilitated Genetics Arrive in Israel
Isracann Bioscience Facilitated Genetics Arrive in Israel
Partner Facility Now Growing Canadian Cannabis Strains
合作伙伴基金現正在培育加拿大大麻菌株
VANCOUVER, British Columbia, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the "Company") a multi-faceted Israel-based company focused on becoming a premier low cost, high quality cannabis producer/distributor is pleased to announce that previously shipped genetics have cleared Israeli customs and are being raised as mother stock.
温哥華，不列顛哥倫比亞省，9月2022年28日(環球通訊社)--Isracann Biosciences Inc.(CSE：IPOT)(XFRA：A2PT0E)(場外交易：ISCNF)(The“公司“)一家總部設在以色列的多方面公司，專注於成為一家領先的低成本、高質量的大麻生產商/經銷商，高興地宣佈，以前運輸的基因已經通過了以色列海關，並正在作為母種飼養。
"The Israeli market will now have access to premium Canadian high THC genetics," notes CEO Phil Floucault. "The three strains we shipped are called: Liberty Haze, Hell Monkey, and Grape Stomper. All three strains have received a positive response from consumers in Canada and I am looking forward to being able to make them available to the Israeli market."
首席執行官菲爾·弗洛科指出：“以色列市場現在可以獲得優質的加拿大高THC基因。”我們發貨的三種菌株分別是：Liberty Haze、Hell Monkey和Grave Stomper。這三種菌株都得到了加拿大消費者的積極反應，我期待着能夠將它們推向以色列市場。
The three strains sent were developed as part of United Greeneries' "Grass Roots" genetics program, the goal of which is to produce novel high THC strains with commercially high yields. Currently being sold as premium cannabis flower in Canada, the three strains represent some of the top preforming genetics in United Greeneries' catalogue. With the support of United Greeneries and Isracann, all three strains have been integrated into the Intelicanna facility and are being prepared as the initial Israeli mother stock.
這三個菌株是作為聯合綠色公司“草根”遺傳計劃的一部分開發的，該計劃的目標是培育出具有商業上高產量的新的高THC菌株。目前在加拿大作為優質大麻花出售，這三個菌株代表了聯合綠色公司目錄中一些頂級的預成型遺傳學。在聯合綠黨和以色列人的支持下，所有三個菌株都被整合到Intelicanna設施中，並正在準備作為最初的以色列母種。
Phil Floucault continues, "The planning and preparation by the teams in Canada and Israel made this genetics shipment happen smoothly. The growing teams are now fully engaged and working to expedite the process of scaling to full production. In the near term, Canadian quality cannabis will be grown in Israel and available to Israeli customers. Canadian genetics, Israeli grown."
Phil Floucault繼續説道：“加拿大和以色列團隊的計劃和準備使這批轉基因大麻順利完成。不斷壯大的團隊現在正全力以赴，努力加快規模化生產的進程。在短期內，加拿大優質大麻將在以色列種植並提供給以色列客户。加拿大遺傳學，以色列種植。”
On Behalf of The Board of Directors
我謹代表董事會
"Phil Floucault"
《菲爾·弗洛科》
Phil Floucault
Chief Executive Officer and President
菲爾·弗洛科
首席執行官兼總裁
About Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF)
Isracann is a multidisciplinary cannabis focused producer and product developer with Israeli-based cannabis production farm assets and a Canadian natural health medicine development and production arm. Concurrently focused on initial retail sales in Canada and in becoming a premier cannabis producer offering low-cost domestic Israeli production, the Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. For more information visit: .
Isracann Biosciences公司簡介(CSE：IPOT)(XFRA：A2PT0E)(場外交易：ISCNF)
Isracann是一家專注於多學科的大麻生產商和產品開發商，擁有以色列的大麻生產農場資產和加拿大天然保健藥物開發和生產部門。該公司同時專注於加拿大的初始零售，併成為提供低成本以色列國內生產的主要大麻生產商，其目標是在加拿大將天然保健藥物商業化，並利用以色列境內的協議獲得進出口機會和藥用大麻種植。有關更多信息，請訪問：。
Contact
Empire Communications Group
+1 (604) 343-2724
info@isracann.com
聯繫方式
帝國通信集團
+1 (604) 343-2724
郵箱：Info@isracann.com
Forward-Looking Information
This release may contain forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Forward-looking statements may include, without limitation, statements relating to the commercial production of Liberty Haze, Hell Monkey and Grape Stomper for the Israeli market. The forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. All forward-looking statements in this press release are made as of the date of this press release. The forward-looking statements contained herein are also subject generally to assumptions and risks and uncertainties that are described from time to time in the Company's documents filed from time to time with the CSE, the British Columbia Securities Commission, the Alberta Securities Commission, and the Ontario Securities Commission. Although Isracann believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Isracann expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
前瞻性信息
本新聞稿可能包含前瞻性陳述。前瞻性陳述是指不是歷史事實的陳述，一般但並非總是以“預期”、“計劃”、“預期”、“相信”、“打算”、“估計”、“項目”、“可能”和類似的表述，或事件或條件“將”、“將”、“可能”、“可能”或“應該”發生。前瞻性表述可能包括但不限於有關為以色列市場商業化生產Liberty Haze、地獄猴和葡萄Stomper的表述。本新聞稿中包含的前瞻性陳述完全受本警告性聲明的限制。本新聞稿中的所有前瞻性陳述都是在本新聞稿發佈之日作出的。本文中包含的前瞻性陳述一般也會受到假設和風險及不確定因素的影響，這些假設和風險及不確定因素在公司不時提交給CSE、不列顛哥倫比亞省證券委員會、艾伯塔省證券委員會和安大略省證券委員會的文件中有所描述。儘管Isracann認為這些前瞻性陳述中表達的預期是基於合理的假設，但這些陳述並不能保證未來的業績，實際結果可能與前瞻性陳述中的結果大不相同。Isracann明確表示不會因新信息、未來事件或其他原因而更新或修改任何前瞻性陳述，也不承擔任何義務。
The CSE does not accept responsibility for the adequacy or accuracy of this release.
CSE不對本新聞稿的充分性或準確性承擔責任。
譯文內容由第三人軟體翻譯。